We want our innovative drugs and therapies to reach patients as quickly as possible.
For this reason, we have launched the Proof-of-Concept (PoC) initiative together with the Fraunhofer Gesellschaft and university medicine. It aims to ensure that preclinical research reaches clinical development more quickly and efficiently throughout Germany.
Together with our partners, we identify promising preclinical and clinical development projects and drive them forward with our expertise.
In most cases, the clinical proof-of-concept (PoC) is crucial: only when this is successful do companies join a project and continue to develop the innovative therapeutic or diagnostic procedures until they are ready for the market.